Dylan Perkins, in Yukon, OK - Medicare Physical Therapist Provider

Dylan Perkins, is a medicare enrolled "Physical Therapist" provider in Yukon, Oklahoma. His current practice location is 740 S Mustang Rd, Yukon, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (405) 494-7070.

Dylan Perkins is licensed to practice in Oklahoma (license number 6532) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1144085911.

Contact Information

	Dylan Perkins,
	740 S Mustang Rd, Yukon, OK 73099-6777
	(405) 494-7070
	Not Available

Healthcare Provider's Profile

Full Name	Dylan Perkins
Gender	Male
Speciality	Physical Therapist
Location	740 S Mustang Rd, Yukon, Oklahoma
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1144085911
Provider Enumeration Date: 02/20/2024
Last Update Date: 02/20/2024

Medicare PECOS Information:

PECOS PAC ID: 5991141129
Enrollment ID: I20240311002808

Medical Identifiers

Medical identifiers for Dylan Perkins such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144085911	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	6532 (Oklahoma)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dylan Perkins allows following entities to bill medicare on his behalf.

Provider Name	Hpc Holdings Llc
Provider Type	Part B Supplier - Physical/occupational Therapy Group In Private Practice
Provider Identifiers	NPI Number: 1396262234 PECOS PAC ID: 6507123874 Enrollment ID: O20171205001149

News Archive

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

United Therapeutics Corporation announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and autologous stem cell transplantation (ASCT).

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.

Study looks at shaken baby syndrome

Crying is the only way a baby can express its feelings and needs. If the parents or caregivers cannot find the cause of the inconsolable crying of the infant, they might react sharply and shake the baby.

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children's Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dylan Perkins is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dylan Perkins, 5300 W Memorial Rd Apt 13l, Oklahoma City, OK 73142-2039 Ph: (623) 419-2522	Dylan Perkins, 740 S Mustang Rd, Yukon, OK 73099-6777 Ph: (405) 494-7070

News Archive

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Study looks at shaken baby syndrome

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

Physical Therapist in Yukon, OK

Miss Emily Michelle Worsham, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1824 Commons Cir Ste B, Yukon, OK 73099 Phone: 405-467-6782 Fax: 405-467-6100
Jacob Mullen, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17 Ivory Dr, Yukon, OK 73099 Phone: 972-259-0606
Elizabeth Anne Younger, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 800 Garth Brooks Blvd, Yukon, OK 73099 Phone: 405-350-3336
Valir Outpatient Clinic #2 Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1115 Garth Brooks Blvd, Yukon, OK 73099 Phone: 405-354-6698 Fax: 405-354-6609
The Therapy Place At Surrey Hills Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11216 Nw Expressway, Yukon, OK 73099 Phone: 405-373-3122 Fax: 405-373-3443
Emily Garfield, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1115 Garth Brooks Blvd, Yukon, OK 73099 Phone: 405-354-6698 Fax: 405-354-6609

Dylan Perkins, - Medicare Physical Therapist in Yukon, OK

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Study looks at shaken baby syndrome

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Study looks at shaken baby syndrome

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

Physical Therapist in Yukon, OK